Biogen Inc (BIIB)
157.59
+1.59
(+1.02%)
USD |
NASDAQ |
Nov 21, 12:07
Biogen Price to Book Value: 1.404 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.390 |
| November 19, 2024 | 1.384 |
| November 18, 2024 | 1.407 |
| November 15, 2024 | 1.425 |
| November 14, 2024 | 1.469 |
| November 13, 2024 | 1.477 |
| November 12, 2024 | 1.499 |
| November 11, 2024 | 1.532 |
| November 08, 2024 | 1.541 |
| November 07, 2024 | 1.549 |
| November 06, 2024 | 1.554 |
| November 05, 2024 | 1.576 |
| November 04, 2024 | 1.546 |
| November 01, 2024 | 1.548 |
| October 31, 2024 | 1.550 |
| October 30, 2024 | 1.614 |
| October 29, 2024 | 1.634 |
| October 28, 2024 | 1.648 |
| October 25, 2024 | 1.618 |
| October 24, 2024 | 1.638 |
| October 23, 2024 | 1.630 |
| October 22, 2024 | 1.656 |
| October 21, 2024 | 1.645 |
| October 18, 2024 | 1.694 |
| October 17, 2024 | 1.688 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.683 |
| October 15, 2024 | 1.706 |
| October 14, 2024 | 1.706 |
| October 11, 2024 | 1.678 |
| October 10, 2024 | 1.680 |
| October 09, 2024 | 1.654 |
| October 08, 2024 | 1.624 |
| October 07, 2024 | 1.633 |
| October 04, 2024 | 1.654 |
| October 03, 2024 | 1.646 |
| October 02, 2024 | 1.681 |
| October 01, 2024 | 1.699 |
| September 30, 2024 | 1.726 |
| September 27, 2024 | 1.785 |
| September 26, 2024 | 1.775 |
| September 25, 2024 | 1.733 |
| September 24, 2024 | 1.780 |
| September 23, 2024 | 1.795 |
| September 20, 2024 | 1.828 |
| September 19, 2024 | 1.847 |
| September 18, 2024 | 1.811 |
| September 17, 2024 | 1.817 |
| September 16, 2024 | 1.830 |
| September 13, 2024 | 1.793 |
| September 12, 2024 | 1.814 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.384
Minimum
Nov 19 2024
5.845
Maximum
Jun 10 2021
3.160
Average
3.118
Median
Feb 14 2023
Price to Book Value Benchmarks
| Eli Lilly and Co | 49.50 |
| Sage Therapeutics Inc | 0.5543 |
| Pfizer Inc | 1.529 |
| Amgen Inc | 20.56 |
| Ionis Pharmaceuticals Inc | 8.296 |
Price to Book Value Related Metrics
| PE Ratio | 14.24 |
| PS Ratio | 2.394 |
| PEG Ratio | 1.418 |
| Price to Free Cash Flow | 13.01 |
| Price | 157.59 |
| Earnings Yield | 7.02% |
| Market Cap | 22.96B |
| PEGY Ratio | 1.418 |
| Operating PE Ratio | 10.33 |
| Normalized PE Ratio | 13.33 |